BetterLife PharmaBETRF -0.18%28 Market Cap is $17.07 Mil as of Jun. 29, 2026. GuruFocus rates BETRF with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,428 Biotechnology companies, BetterLife Pharma ranks worse than 78.22% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BetterLife Pharma's share price for the quarter that ended in Apr. 2026 was $0.05. BetterLife Pharma's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 154.43 Mil. Therefore, BetterLife Pharma's market cap for the quarter that ended in Apr. 2026 was $7.72 Mil.
BetterLife Pharma's quarterly market cap
declined
from Jul. 2025 ($11.22 Mil) to Jan. 2026 ($5.77 Mil) but then
increased
from Jan. 2026 ($5.77 Mil) to Apr. 2026 ($7.72 Mil).
BetterLife Pharma's annual market cap
increased
from Jan. 2024 ($6.49 Mil) to Jan. 2025 ($11.50 Mil) but then
declined
from Jan. 2025 ($11.50 Mil) to Jan. 2026 ($5.77 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BetterLife Pharma's Enterprise Value for Today is $20.28 Mil.
BetterLife Pharma (OTCPK:BETRF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BetterLife Pharma Market Cap Related Terms
BetterLife Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for BetterLife Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, BetterLife Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BetterLife Pharma Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where BetterLife Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BetterLife Pharma's Market Cap for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BetterLife Pharma (BETRF) has a Market Cap of $17.07 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BetterLife Pharma and its competitors. According to the industry distribution chart, BetterLife Pharma ranks #1117 out of 1428 companies in the Biotechnology industry, placing it in the top 78.2%.
Is BetterLife Pharma's Market Cap too high?
BetterLife Pharma's current Market Cap is $17.07 Mil. The Biotechnology industry median Market Cap is 114.03. BetterLife Pharma's value of $17.07 Mil is 85% below this industry median. Based on the distribution chart, BetterLife Pharma ranks #1117 out of 1428 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BetterLife Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BetterLife Pharma ranks #1117 out of 1428 companies for Market Cap. This places BetterLife Pharma in the lower half of its industry. The industry median Market Cap is 114.03. BetterLife Pharma's value of $17.07 Mil is 85% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.03, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BetterLife Pharma's current Market Cap of $17.07 Mil is 85% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BetterLife Pharma and its competitors. For the Biotechnology industry, the median Market Cap is 114.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BetterLife Pharma's current Market Cap is $17.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current Market Cap of $17.07 Mil. The current Market Cap is $17.07 Mil and 85% below the Biotechnology industry median of 114.03. BetterLife Pharma's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Market Cap is $17.07 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
28GF Score
Get the complete analysis for BETRF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BETRF has been successfully added to your 
